Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
Report an inappropriate content
Please select one of the options below.
  • Length
    AllShort (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
  • Date
    AllPast 24 hoursPast weekPast monthPast year
  • Resolution
    AllLower than 360p360p or higher480p or higher720p or higher1080p or higher
  • Source
    All
    Dailymotion
    Vimeo
    Metacafe
    Hulu
    VEVO
    Myspace
    MTV
    CBS
    Fox
    CNN
    MSN
  • Price
    AllFreePaid
  • Clear filters
  • SafeSearch:
  • Moderate
    StrictModerate (default)Off
Filter
NEJM on Instagram: "Persons with two high-risk APOL1 variants have an increased risk of proteinuric kidney disease, including focal segmental glomerulosclerosis. Inaxaplin holds promise as a potential treatment. New research findings are summarized in a short video. Full trial results available at the link in our bio."
2:06
NEJM on Instagram: "Persons with two high-risk APOL1 variants hav…
44.7K viewsMar 18, 2023
Instagramnejm
2023 Notable Articles | New England Journal of Medicine
1:27
2023 Notable Articles | New England Journal of Medicine
8.2K viewsDec 26, 2023
YouTubeNEJM Group
𝗩𝗘𝗥𝗧𝗘𝗫 𝗣𝗛𝗔𝗥𝗠𝗔𝗖𝗘𝗨𝗧𝗜𝗖𝗔𝗟𝗦 (𝗩𝗥𝗧𝗫) 𝗦𝗧𝗢𝗖𝗞 𝗔𝗡𝗔𝗟𝗬𝗦𝗜𝗦 𝟮𝟬𝟮𝟱 | 𝗗𝗖𝗙 𝗩𝗔𝗟𝗨𝗔𝗧𝗜𝗢𝗡, 𝗣𝗜𝗣𝗘𝗟𝗜𝗡𝗘 𝗢𝗨𝗧𝗟𝗢𝗢𝗞
7:42
𝗩𝗘𝗥𝗧𝗘𝗫 𝗣𝗛𝗔𝗥𝗠𝗔𝗖𝗘𝗨𝗧𝗜𝗖𝗔𝗟𝗦 (𝗩𝗥𝗧𝗫) 𝗦𝗧𝗢𝗖𝗞 𝗔𝗡𝗔𝗟𝗬𝗦𝗜𝗦 𝟮𝟬𝟮𝟱 | 𝗗𝗖𝗙 𝗩𝗔𝗟𝗨𝗔𝗧𝗜𝗢𝗡, 𝗣𝗜𝗣𝗘𝗟𝗜𝗡𝗘 𝗢𝗨𝗧𝗟𝗢𝗢𝗞
26 views1 month ago
YouTubeAI Biopharma Playbook
Focal Segmental Glomerulosclerosis (FSGS) - Dr. Ladan Zand (Rochester, MA, USA)
57:22
Focal Segmental Glomerulosclerosis (FSGS) - Dr. L…
1.4K viewsAug 25, 2023
YouTubeMARKUS at HOMe
Persons with two high-risk APOL1 variants have an increased risk of proteinuric kidney disease, including focal segmental glomerulosclerosis. Inaxaplin holds promise as a potential treatment. New research findings are summarized in a short video. https://nej.md/3Te6NGr | The New England Journal of Medicine
2:07
Persons with two high-risk APOL1 variants have an increased risk of …
2K viewsMar 15, 2023
FacebookThe New England Journal of Medicine
🔥 Today’s Best S&P 500 Stocks (December 3, 2025) 🔥
0:13
🔥 Today’s Best S&P 500 Stocks (December 3, 2025) 🔥
920 views2 weeks ago
YouTubeStockometry
$VRTX Vertex Pharmaceuticals Q3 2025 Earnings Conference Call
1:00:34
$VRTX Vertex Pharmaceuticals Q3 2025 Earnings Conference Call
17 views1 month ago
YouTubeEARNMOAR
1:00:37
$VRTX Vertex Pharmaceuticals Q2 2025 Earnings Conference Call
99 views4 months ago
YouTubeEARNMOAR
11:07
🧬 Vertex Pharmaceuticals $VRTX
12 views1 month ago
YouTubeNexus Finance
1:09:36
Vertex公布2024年财报，全年营收110.2亿美元。三联药物TRIKAFTA/K…
92 views10 months ago
bilibiliEureka_zl
See more videos
Static thumbnail place holder
More like this
Feedback
  • Privacy
  • Terms